Steven Elms
SlowingNamed in filings at Aisling CapitalOn the current fund
- Board seats filed
- 12
- Named on a board
- 1
all filings on record
Named in filings at Aisling CapitalOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Marker Therapeutics | Not yet classified | December 2024 | None on file |
| Treeline Biosciences | Biotech & pharma | April 2021 | ARCH Venture Partners, Orbimed Asia Partners, Orbimed Genesis |
| Elevation Oncology | Biotech & pharma | July 2019 | Venbio Global Strategic |
| Ajax Health II | Medical devices | April 2019 | Healthquest Partners, Sofinnova Venture Partners |
| Advion | Not yet classified | June 2014 | None on file |
| K2 THERAPEUTICS | Not yet classified | May 2014 | None on file |
| Loxo Oncology | Biotech & pharma | April 2014 | Orbimed Asia Partners, Orbimed Genesis |
| EarLens | Medical devices | February 2014 | Lightstone Singapore, Lightstone Ventures |
| TRIA Beauty | Medical devices | November 2013 | Vivo Innovation |
| LensAR | Medical devices | March 2012 | None on file |
| ADMA PLASMA BIOLOGICS | Not yet classified | February 2012 | None on file |
| ADMA BIOLOGICS | Not yet classified | February 2012 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Steven Elms on the board, based on 7 filed seats with a verified or cited source.
5 more filed seats not yet classified, left out of the shares above.